Jamjoom Pharmaceuticals Factory Co. (4015)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Major Shareholders
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

{{ 'components.chart.period.' + period | translate }}

{{ 'components.chart.type.' + type | translate }}

This mark means that there are news on this date.

Stock

Par Value 10.0 Saudi Riyal

Market Cap 8,526,000,000.00 Saudi Riyal

Book Value (BVPS) 24.03 Saudi Riyal Based on: Second Quarter 2025

P/B Ratio 6.27 Last update: 2026-08-15

EPS 7.54 Saudi Riyal Based on: Second Quarter 2025

P/E Ratio 16.13 Last update: 2026-08-15

Trading Currency Saudi Riyal

Company Statistics

News

Jamjoom Pharma inks exclusive deal with Switzerland’s Idorsia Company News

Tadawul registers SAR 166m in total negotiated deals on 23 July Trading Activities

Jamjoom Pharma witnesses negotiated deal of SAR 3.5m Company News

Jamjoom Pharma seals binding agreement with PIF-owned Lifera Company News

Jamjoom Pharma unveils SAR 154m interim dividends for H1-26 Cash Dividends

Jamjoom Pharma’s net profits up to SAR 306m in H1-26 Financial Results

Market Announcements